DOXAZOSIN MESYLATE

DOXAZOSIN MESYLATE was reported 36429 times

DOXAZOSIN MESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 27 0.9000
1 SPIROMETRY ABNORMAL 298 0.4983
2 MITE ALLERGY 297 0.4534
3 MYCOTIC ALLERGY 297 0.3474
4 PULMONARY VASCULITIS 170 0.3160
5 DUST ALLERGY 301 0.3068
6 VENA CAVA INJURY 28 0.3043
7 TOTAL LUNG CAPACITY ABNORMAL 116 0.2982
8 CAPILLARITIS 77 0.2790
9 CONJUNCTIVITIS ALLERGIC 313 0.2112
10 RENAL CYST HAEMORRHAGE 40 0.1770
11 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 124 0.1692
12 RENIN INCREASED 31 0.1136
13 NEURITIS 173 0.1120
14 MYCOBACTERIUM TEST POSITIVE 23 0.1117
15 NORMOCHROMIC NORMOCYTIC ANAEMIA 318 0.1058
16 ABDOMINAL WALL HAEMORRHAGE 25 0.0958
17 VASCULAR COMPRESSION 28 0.0886
18 CAROTID ARTERIOSCLEROSIS 89 0.0862
19 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 26 0.0858
20 CARDIOSPASM 45 0.0806
21 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 159 0.0779
22 RECTAL PROLAPSE 86 0.0712
23 IMMUNISATION 29 0.0668
24 DELAYED GRAFT FUNCTION 45 0.0633
25 RENAL ARTERY STENOSIS 85 0.0616
26 PALMOPLANTAR KERATODERMA 43 0.0593
27 RESPIRATORY SYMPTOM 166 0.0583
28 PHAEOCHROMOCYTOMA 37 0.0561
29 HYPERPARATHYROIDISM SECONDARY 130 0.0518
30 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 46 0.0433
31 ARTERIOSCLEROSIS CORONARY ARTERY 281 0.0424
32 FORCED EXPIRATORY VOLUME DECREASED 119 0.0420
33 NEPHROGENIC ANAEMIA 193 0.0416
34 ARTERIOSCLEROSIS 390 0.0414
35 SCROTAL OEDEMA 27 0.0380
36 AORTIC DILATATION 41 0.0369
37 INTERVERTEBRAL DISC SPACE NARROWING 28 0.0347
38 EROSIVE DUODENITIS 26 0.0325
39 PULMONARY ALVEOLAR HAEMORRHAGE 179 0.0319
40 COMPLICATIONS OF TRANSPLANTED KIDNEY 71 0.0313
41 FULL BLOOD COUNT ABNORMAL 326 0.0308
42 NEUROLOGICAL SYMPTOM 175 0.0306
43 LEFT VENTRICULAR HYPERTROPHY 127 0.0296
44 BENIGN PROSTATIC HYPERPLASIA 138 0.0267
45 NODULE 310 0.0237
46 ATRIAL TACHYCARDIA 49 0.0233
47 OBSTRUCTIVE AIRWAYS DISORDER 256 0.0230
48 BLADDER PROLAPSE 26 0.0213
49 ATRIOVENTRICULAR BLOCK FIRST DEGREE 92 0.0212
50 HYPERTENSIVE CRISIS 233 0.0209
51 AORTIC ARTERIOSCLEROSIS 53 0.0206
52 HYPERPARATHYROIDISM 42 0.0204
53 VASCULITIS 231 0.0198
54 ACTINIC KERATOSIS 51 0.0196
55 ORTHOSTATIC HYPOTENSION 342 0.0196
56 NEPHROGENIC SYSTEMIC FIBROSIS 57 0.0188
57 NEPHRECTOMY 28 0.0188
58 PRURITUS GENITAL 44 0.0187
59 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 312 0.0184
60 END STAGE RENAL DISEASE 335 0.0183
61 BLOOD PRESSURE INADEQUATELY CONTROLLED 110 0.0183
62 HYPERTENSIVE HEART DISEASE 33 0.0176
63 BLADDER TRANSITIONAL CELL CARCINOMA 25 0.0174
64 AORTIC VALVE INCOMPETENCE 72 0.0169
65 REBOUND ACID HYPERSECRETION 51 0.0168
66 URINE FLOW DECREASED 40 0.0167
67 PRODUCT MONITORING ERROR 24 0.0166
68 ESSENTIAL HYPERTENSION 30 0.0164
69 BRADYARRHYTHMIA 26 0.0158
70 ORTHOPNOEA 50 0.0157
71 CAROTID ARTERY OCCLUSION 57 0.0156
72 HYPERKALAEMIA 533 0.0152
73 HEPATOSPLENOMEGALY 39 0.0152
74 MEAN CELL VOLUME INCREASED 39 0.0152
75 DIABETIC NEPHROPATHY 33 0.0150
76 COLONIC POLYP 24 0.0145
77 KIDNEY FIBROSIS 25 0.0144
78 BLOOD PRESSURE DIASTOLIC ABNORMAL 36 0.0141
79 SKIN INDURATION 29 0.0140
80 TENSION HEADACHE 60 0.0139
81 BLOOD PRESSURE SYSTOLIC ABNORMAL 34 0.0137
82 RENAL CYST 108 0.0136
83 DIVERTICULUM INTESTINAL 59 0.0135
84 KIDNEY TRANSPLANT REJECTION 60 0.0125
85 RENAL FAILURE CHRONIC 96 0.0125
86 DILATATION VENTRICULAR 26 0.0124
87 VENOUS THROMBOSIS LIMB 25 0.0121
88 HYPOXIA 425 0.0121
89 PULMONARY FIBROSIS 229 0.0119
90 AZOTAEMIA 47 0.0118
91 HYPERURICAEMIA 47 0.0114
92 TACHYARRHYTHMIA 28 0.0112
93 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 37 0.0112
94 PRODUCTIVE COUGH 532 0.0111
95 JAUNDICE CHOLESTATIC 39 0.0110
96 ANURIA 95 0.0110
97 BUNDLE BRANCH BLOCK LEFT 46 0.0108
98 ISCHAEMIC CARDIOMYOPATHY 33 0.0108
99 PRESYNCOPE 261 0.0107
100 HYPOMAGNESAEMIA 149 0.0107
101 HAEMORRHAGIC ANAEMIA 46 0.0105
102 SLEEP TERROR 44 0.0104
103 SPINAL STENOSIS 43 0.0104
104 GLOMERULAR FILTRATION RATE DECREASED 128 0.0104
105 VENTRICULAR HYPERTROPHY 26 0.0104
106 AORTIC STENOSIS 36 0.0103
107 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 52 0.0103
108 PROSTATITIS 31 0.0102
109 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 90 0.0102
110 CARDIOMEGALY 125 0.0102
111 NOCTURIA 123 0.0101
112 SKIN HYPERTROPHY 28 0.0100
113 BLOOD CREATINE INCREASED 44 0.0099
114 SINUS BRADYCARDIA 96 0.0099
115 CHRONIC KIDNEY DISEASE 754 0.0099
116 HYPONATRAEMIA 558 0.0099
117 PROSTATIC DISORDER 54 0.0098
118 SQUAMOUS CELL CARCINOMA OF SKIN 59 0.0098
119 DIASTOLIC DYSFUNCTION 30 0.0097
120 BLOOD UREA INCREASED 162 0.0097
121 COMA SCALE ABNORMAL 28 0.0097
122 PRIAPISM 33 0.0096
123 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 39 0.0095
124 CORONARY ARTERY STENOSIS 48 0.0095
125 MITRAL VALVE INCOMPETENCE 108 0.0095
126 METABOLIC ACIDOSIS 303 0.0095
127 TRICUSPID VALVE INCOMPETENCE 75 0.0094
128 GLOMERULONEPHRITIS 23 0.0094
129 HAEMOPTYSIS 260 0.0093
130 ATRIOVENTRICULAR BLOCK 72 0.0093
131 BLOOD POTASSIUM INCREASED 149 0.0092
132 SYNCOPE 908 0.0091
133 RENAL FAILURE ACUTE 384 0.0090
134 APLASIA PURE RED CELL 31 0.0090
135 TUBULOINTERSTITIAL NEPHRITIS 167 0.0089
136 DYSLIPIDAEMIA 45 0.0089
137 OLIGURIA 55 0.0089
138 SPINAL OSTEOARTHRITIS 77 0.0088
139 BLOOD LACTIC ACID INCREASED 46 0.0087
140 BRADYCARDIA 463 0.0087
141 HAEMODIALYSIS 73 0.0087
142 EXCORIATION 22 0.0087
143 UPPER GASTROINTESTINAL HAEMORRHAGE 144 0.0086
144 POLYURIA 70 0.0085
145 DIZZINESS POSTURAL 82 0.0084
146 MELAENA 185 0.0084
147 WHEEZING 497 0.0084
148 GRANULOMA 29 0.0084
149 LARGE INTESTINE POLYP 58 0.0084
150 ACUTE KIDNEY INJURY 1271 0.0083
151 ATRIOVENTRICULAR BLOCK COMPLETE 55 0.0082
152 VITAMIN D DECREASED 70 0.0082
153 SOPOR 108 0.0081
154 PROSTATOMEGALY 32 0.0081
155 CLONUS 22 0.0080
156 CAROTID ARTERY STENOSIS 28 0.0080
157 ACIDOSIS 61 0.0080
158 GASTRITIS EROSIVE 37 0.0079
159 HYPOTHYROIDISM 251 0.0079
160 RENAL IMPAIRMENT 653 0.0078
161 OBSTRUCTION 31 0.0078
162 MYOPATHY 67 0.0077
163 SUBARACHNOID HAEMORRHAGE 79 0.0077
164 BLOOD URIC ACID INCREASED 44 0.0076
165 HYPOKALAEMIA 350 0.0076
166 BLOOD CREATININE INCREASED 495 0.0076
167 PERIORBITAL OEDEMA 39 0.0075
168 DIABETIC RETINOPATHY 25 0.0074
169 GOUT 132 0.0073
170 RENAL TUBULAR NECROSIS 72 0.0073
171 CIRCULATORY COLLAPSE 125 0.0073
172 CARDIAC MURMUR 63 0.0073
173 RENAL FAILURE 963 0.0072
174 PULSELESS ELECTRICAL ACTIVITY 30 0.0072
175 BLOOD PRESSURE SYSTOLIC INCREASED 140 0.0072
176 DRUG INTERACTION 1137 0.0072
177 ECCHYMOSIS 49 0.0071
178 HYPERCHOLESTEROLAEMIA 69 0.0071
179 BLOOD PRESSURE FLUCTUATION 171 0.0071
180 URINARY INCONTINENCE 210 0.0071
181 DUODENAL ULCER 50 0.0071
182 BLOOD PRESSURE DIASTOLIC DECREASED 52 0.0070
183 MYOCARDIAL ISCHAEMIA 80 0.0070
184 ATRIAL FLUTTER 56 0.0070
185 PERIPHERAL VASCULAR DISORDER 36 0.0070
186 DIVERTICULUM 49 0.0069
187 POTENTIATING DRUG INTERACTION 23 0.0068
188 HYPOVOLAEMIA 40 0.0068
189 HYPOGLYCAEMIA 329 0.0068
190 BUNDLE BRANCH BLOCK RIGHT 31 0.0067
191 NEPHROPATHY 63 0.0067
192 SUBDURAL HAEMATOMA 96 0.0067
193 LEFT VENTRICULAR FAILURE 23 0.0067
194 LOWER GASTROINTESTINAL HAEMORRHAGE 49 0.0066
195 ANGINA UNSTABLE 43 0.0066
196 FACIAL PAIN 59 0.0066
197 HYPOTENSION 1325 0.0066
198 BASAL CELL CARCINOMA 103 0.0066
199 VENTRICULAR TACHYCARDIA 109 0.0066
200 CARDIAC FAILURE CHRONIC 28 0.0066
201 ERECTILE DYSFUNCTION 168 0.0065
202 BRONCHIOLITIS 23 0.0065
203 HYPERLIPIDAEMIA 78 0.0065
204 HYPOCALCAEMIA 123 0.0065
205 LACTIC ACIDOSIS 208 0.0064
206 PROTEINURIA 122 0.0064
207 URINARY RETENTION 214 0.0064
208 OEDEMA PERIPHERAL 777 0.0064
209 CORONARY ARTERY DISEASE 193 0.0064
210 VENTRICULAR EXTRASYSTOLES 66 0.0063
211 ATRIAL FIBRILLATION 614 0.0063
212 HYPERVOLAEMIA 31 0.0063
213 DIABETIC NEUROPATHY 31 0.0063
214 CONGESTIVE CARDIOMYOPATHY 26 0.0062
215 HAEMATURIA 213 0.0062
216 WOUND HAEMORRHAGE 23 0.0062
217 LIP SWELLING 205 0.0061
218 PERIPHERAL ISCHAEMIA 25 0.0061
219 LEFT VENTRICULAR DYSFUNCTION 41 0.0061
220 IRON DEFICIENCY ANAEMIA 56 0.0061
221 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 62 0.0060
222 ANGINA PECTORIS 173 0.0060
223 LYMPHOEDEMA 41 0.0059
224 THROMBOSIS 477 0.0059
225 INTERNATIONAL NORMALISED RATIO INCREASED 169 0.0059
226 MIDDLE INSOMNIA 110 0.0059
227 HYDRONEPHROSIS 44 0.0059
228 ISCHAEMIA 27 0.0059
229 RENAL INJURY 174 0.0059
230 DIALYSIS 83 0.0058
231 NEPHROTIC SYNDROME 40 0.0058
232 CORONARY ARTERY OCCLUSION 80 0.0058
233 ANAPHYLACTOID REACTION 24 0.0058
234 CEREBRAL ISCHAEMIA 30 0.0058
235 IRON DEFICIENCY 26 0.0058
236 GASTRIC ULCER HAEMORRHAGE 32 0.0058
237 EOSINOPHILIA 101 0.0058
238 EXERCISE TOLERANCE DECREASED 33 0.0057
239 DYSURIA 209 0.0057
240 UROSEPSIS 52 0.0056
241 ANGIOEDEMA 249 0.0056
242 ASTHMA 636 0.0056
243 ELECTROCARDIOGRAM ABNORMAL 44 0.0056
244 BLOOD COUNT ABNORMAL 85 0.0056
245 URINE OUTPUT DECREASED 49 0.0056
246 ACUTE MYOCARDIAL INFARCTION 165 0.0056
247 PROSTATIC SPECIFIC ANTIGEN INCREASED 77 0.0056
248 GINGIVITIS 30 0.0056
249 HYPERTENSION 1173 0.0055
250 TRANSIENT ISCHAEMIC ATTACK 186 0.0055
251 ABDOMINAL TENDERNESS 27 0.0054
252 SUPRAVENTRICULAR TACHYCARDIA 52 0.0054
253 GINGIVAL BLEEDING 74 0.0054
254 RHABDOMYOLYSIS 226 0.0054
255 PROTEIN URINE PRESENT 27 0.0054
256 ESCHERICHIA URINARY TRACT INFECTION 23 0.0054
257 OESOPHAGITIS 59 0.0054
258 POLLAKIURIA 225 0.0054
259 MICTURITION URGENCY 61 0.0053
260 SKIN TIGHTNESS 25 0.0053
261 PURPURA 47 0.0053
262 CARDIAC FAILURE CONGESTIVE 425 0.0053
263 LUNG DISORDER 259 0.0053
264 BLOOD PRESSURE SYSTOLIC DECREASED 24 0.0053
265 SPRUE-LIKE ENTEROPATHY 26 0.0053
266 GASTRIC ULCER 100 0.0053
267 AORTIC ANEURYSM 40 0.0053
268 SWELLING OF EYELID 33 0.0053
269 DERMATITIS BULLOUS 38 0.0052
270 THROMBOTIC MICROANGIOPATHY 51 0.0052
271 HYPERNATRAEMIA 26 0.0052
272 RHINITIS 42 0.0052
273 DIABETES MELLITUS INADEQUATE CONTROL 92 0.0052
274 BLOOD PRESSURE ABNORMAL 103 0.0052
275 HAEMORRHOIDS 101 0.0052
276 RECTAL HAEMORRHAGE 219 0.0051
277 PULMONARY EMBOLISM 484 0.0051
278 SLEEP APNOEA SYNDROME 97 0.0051
279 PANCREATITIS ACUTE 114 0.0051
280 BLOOD PRESSURE INCREASED 775 0.0051
281 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 359 0.0050
282 PULMONARY HYPERTENSION 105 0.0050
283 LUMBAR VERTEBRAL FRACTURE 23 0.0050
284 CARDIAC FAILURE ACUTE 33 0.0049
285 HIATUS HERNIA 64 0.0049
286 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 237 0.0049
287 CEREBRAL HAEMORRHAGE 176 0.0049
288 SHOCK 113 0.0049
289 PULMONARY OEDEMA 220 0.0049
290 NEUTROPENIC SEPSIS 35 0.0049
291 CARDIAC VALVE DISEASE 28 0.0049
292 PHARYNGOLARYNGEAL PAIN 26 0.0049
293 HEPATIC STEATOSIS 91 0.0049
294 BREATH SOUNDS ABNORMAL 24 0.0049
295 GASTROENTERITIS 71 0.0049
296 HAEMATOMA 125 0.0048
297 SWOLLEN TONGUE 150 0.0048
298 VENTRICULAR FIBRILLATION 53 0.0048
299 ISCHAEMIC STROKE 85 0.0048
300 HAEMORRHAGIC STROKE 37 0.0047
301 POLYP 31 0.0047
302 INCONTINENCE 50 0.0047
303 SOMNAMBULISM 31 0.0047
304 ACUTE CORONARY SYNDROME 39 0.0047
305 HAEMOGLOBIN DECREASED 482 0.0047
306 BLOOD PRESSURE DECREASED 310 0.0047
307 INFLAMMATORY MARKER INCREASED 23 0.0046
308 HAEMATOCRIT DECREASED 92 0.0046
309 RED BLOOD CELL COUNT DECREASED 132 0.0046
310 INJECTION SITE INFLAMMATION 23 0.0046
311 HEART RATE IRREGULAR 104 0.0046
312 LOSS OF CONSCIOUSNESS 589 0.0046
313 HEART RATE DECREASED 161 0.0046
314 DECREASED INTEREST 27 0.0046
315 CARDIAC FAILURE 367 0.0046
316 C-REACTIVE PROTEIN INCREASED 166 0.0046
317 GROIN PAIN 40 0.0046
318 DYSPNOEA EXERTIONAL 170 0.0045
319 BLOOD SODIUM DECREASED 85 0.0045
320 PEMPHIGOID 34 0.0045
321 OEDEMA 244 0.0045
322 GASTROINTESTINAL HAEMORRHAGE 375 0.0045
323 FAECES DISCOLOURED 97 0.0045
324 HAEMATEMESIS 112 0.0044
325 CELLULITIS 222 0.0044
326 ABNORMAL LOSS OF WEIGHT 30 0.0044
327 SALIVARY HYPERSECRETION 44 0.0044
328 FLUID OVERLOAD 64 0.0044
329 BLOOD CREATINE PHOSPHOKINASE INCREASED 126 0.0044
330 HYPERGLYCAEMIA 159 0.0044
331 HEAD INJURY 138 0.0044
332 CONFUSIONAL STATE 704 0.0044
333 PROTHROMBIN TIME PROLONGED 26 0.0043
334 ATELECTASIS 42 0.0043
335 CARDIAC FLUTTER 28 0.0043
336 HEPATITIS CHOLESTATIC 26 0.0043
337 RALES 25 0.0043
338 ANGIOPATHY 24 0.0043
339 LETHARGY 246 0.0043
340 HYPERTRIGLYCERIDAEMIA 25 0.0043
341 TENSION 26 0.0043
342 ANAEMIA 812 0.0043
343 MUSCLE TWITCHING 98 0.0042
344 DIPLOPIA 110 0.0042
345 THERMAL BURN 30 0.0042
346 ANOSMIA 61 0.0042
347 CONCOMITANT DISEASE AGGRAVATED 26 0.0042
348 MUSCLE ATROPHY 53 0.0042
349 HYPERKERATOSIS 23 0.0042
350 LIVER FUNCTION TEST ABNORMAL 121 0.0042
351 EXTRASYSTOLES 29 0.0041
352 ANHEDONIA 109 0.0041
353 UNRESPONSIVE TO STIMULI 107 0.0041
354 LOWER RESPIRATORY TRACT INFECTION 188 0.0041
355 ARRHYTHMIA 195 0.0041
356 NEPHROPATHY TOXIC 46 0.0041
357 PULMONARY MASS 61 0.0041
358 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 213 0.0041
359 BRADYKINESIA 24 0.0041
360 LARYNGEAL OEDEMA 25 0.0041
361 RENAL PAIN 43 0.0041
362 BLOOD URINE PRESENT 77 0.0041
363 EJECTION FRACTION DECREASED 63 0.0040
364 ELECTROLYTE IMBALANCE 47 0.0040
365 MYOSITIS 36 0.0040
366 EPISTAXIS 299 0.0040
367 SEROTONIN SYNDROME 76 0.0040
368 BLOOD TESTOSTERONE DECREASED 27 0.0039
369 INGUINAL HERNIA 24 0.0039
370 MUSCULOSKELETAL CHEST PAIN 61 0.0039
371 BLOOD CALCIUM DECREASED 44 0.0039
372 RESTLESS LEGS SYNDROME 71 0.0039
373 LARGE INTESTINE PERFORATION 27 0.0039
374 PALPITATIONS 455 0.0039
375 ANOREXIA 50 0.0039
376 CARDIAC PACEMAKER INSERTION 23 0.0039
377 DEHYDRATION 513 0.0038
378 COAGULOPATHY 64 0.0038
379 GASTRITIS 101 0.0038
380 MOUTH HAEMORRHAGE 28 0.0038
381 PLEURAL EFFUSION 232 0.0038
382 EYE INFECTION 43 0.0038
383 SHOCK HAEMORRHAGIC 31 0.0038
384 THIRST 68 0.0038
385 AMNESIA 247 0.0038
386 MUSCULAR WEAKNESS 431 0.0038
387 PHARYNGITIS 47 0.0038
388 HEMIPARESIS 64 0.0038
389 HICCUPS 31 0.0038
390 MULTI-ORGAN FAILURE 65 0.0038
391 RENAL DISORDER 175 0.0038
392 HYPOTHERMIA 38 0.0037
393 HAEMORRHAGE INTRACRANIAL 56 0.0037
394 BLADDER DISORDER 37 0.0037
395 MYASTHENIA GRAVIS 30 0.0037
396 NEUTROPHIL COUNT INCREASED 38 0.0037
397 DYSARTHRIA 139 0.0037
398 BRADYPHRENIA 24 0.0037
399 SPLENOMEGALY 43 0.0037
400 ECONOMIC PROBLEM 55 0.0036
401 CARDIOGENIC SHOCK 52 0.0036
402 TOXIC EPIDERMAL NECROLYSIS 55 0.0036
403 TINNITUS 166 0.0036
404 HALLUCINATION 272 0.0036
405 RESPIRATORY RATE INCREASED 32 0.0036
406 STENT PLACEMENT 29 0.0036
407 ACUTE RESPIRATORY FAILURE 69 0.0036
408 FAECES SOFT 26 0.0036
409 GLYCOSYLATED HAEMOGLOBIN INCREASED 90 0.0036
410 HYPERCALCAEMIA 44 0.0036
411 ARTERIAL OCCLUSIVE DISEASE 28 0.0036
412 CEREBRAL INFARCTION 87 0.0036
413 SKIN ULCER 92 0.0036
414 FLUID RETENTION 181 0.0036
415 FEELING COLD 99 0.0036
416 DYSPNOEA 2010 0.0035
417 TENDERNESS 37 0.0035
418 DIZZINESS 1769 0.0035
419 MEDICATION ERROR 197 0.0035
420 HEPATITIS ACUTE 23 0.0035
421 TACHYPNOEA 48 0.0035
422 JOINT SWELLING 424 0.0035
423 DRUG LEVEL INCREASED 58 0.0035
424 PERICARDIAL EFFUSION 81 0.0035
425 FACE OEDEMA 59 0.0035
426 SUDDEN DEATH 37 0.0035
427 VITAMIN D DEFICIENCY 34 0.0035
428 NEOPLASM 40 0.0035
429 CHOLELITHIASIS 114 0.0035
430 PYELONEPHRITIS 30 0.0035
431 BLOOD POTASSIUM DECREASED 104 0.0035
432 HALLUCINATION, VISUAL 73 0.0035
433 DISORIENTATION 137 0.0035
434 SWELLING FACE 225 0.0035
435 ELECTROCARDIOGRAM QT PROLONGED 124 0.0034
436 VERTIGO 210 0.0034
437 MYOCARDIAL INFARCTION 600 0.0034
438 DELIRIUM 119 0.0034
439 LEUKOCYTOSIS 62 0.0034
440 FEAR 92 0.0034
441 SMALL INTESTINAL OBSTRUCTION 42 0.0034
442 ASTHENIA 1280 0.0034
443 JAUNDICE 91 0.0034
444 BLOOD DISORDER 27 0.0034
445 MYALGIA 572 0.0034
446 MENTAL STATUS CHANGES 93 0.0033
447 PERICARDITIS 56 0.0033
448 VISUAL FIELD DEFECT 24 0.0033
449 DIVERTICULITIS 92 0.0033
450 DRY MOUTH 269 0.0033
451 HYPOKINESIA 48 0.0033
452 CHEST PAIN 611 0.0033
453 PERIPHERAL SWELLING 505 0.0033
454 BLOOD ALBUMIN DECREASED 26 0.0033
455 BODY HEIGHT DECREASED 35 0.0033
456 LOCAL SWELLING 57 0.0033
457 SPINAL COMPRESSION FRACTURE 27 0.0033
458 BLINDNESS TRANSIENT 24 0.0033
459 BLOOD MAGNESIUM DECREASED 28 0.0032
460 TACHYCARDIA 288 0.0032
461 SINUS TACHYCARDIA 46 0.0032
462 CARDIAC ARREST 267 0.0032
463 GENERALISED OEDEMA 40 0.0032
464 DIABETES MELLITUS 245 0.0032
465 NIGHTMARE 111 0.0032
466 FLANK PAIN 30 0.0032
467 TORSADE DE POINTES 25 0.0032
468 DROOLING 22 0.0032
469 PETECHIAE 33 0.0032
470 ILEUS 39 0.0031
471 PULMONARY CONGESTION 41 0.0031
472 FALL 1031 0.0031
473 BODY TEMPERATURE INCREASED 63 0.0031
474 LACERATION 29 0.0031
475 DECUBITUS ULCER 25 0.0031
476 COLD SWEAT 54 0.0031
477 BLOOD ALKALINE PHOSPHATASE INCREASED 76 0.0031
478 LUNG INFILTRATION 27 0.0031
479 PRURITUS GENERALISED 66 0.0030
480 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 29 0.0030
481 HOSPICE CARE 30 0.0030
482 EYE PRURITUS 102 0.0030
483 RESPIRATORY FAILURE 221 0.0030
484 TROPONIN INCREASED 23 0.0030
485 HAEMODYNAMIC INSTABILITY 23 0.0030
486 BALANCE DISORDER 259 0.0030
487 DYSPEPSIA 294 0.0030
488 VISUAL ACUITY REDUCED 99 0.0030
489 EMPHYSEMA 30 0.0030
490 GASTROOESOPHAGEAL REFLUX DISEASE 238 0.0030
491 KIDNEY INFECTION 58 0.0030
492 GASTRIC HAEMORRHAGE 34 0.0030
493 DRY THROAT 30 0.0029
494 APHASIA 89 0.0029
495 CHEST DISCOMFORT 301 0.0029
496 COGNITIVE DISORDER 137 0.0029
497 FACIAL PARALYSIS 25 0.0029
498 ASCITES 86 0.0029
499 URINARY TRACT INFECTION 499 0.0029
500 CLOSTRIDIUM DIFFICILE COLITIS 31 0.0029
501 WOUND INFECTION 32 0.0029
502 BLOOD GLUCOSE FLUCTUATION 32 0.0029
503 DIABETIC KETOACIDOSIS 70 0.0029
504 CARDIOMYOPATHY 43 0.0029
505 SKIN HYPERPIGMENTATION 25 0.0029
506 HAEMOLYTIC ANAEMIA 26 0.0029
507 BLINDNESS 118 0.0029
508 EOSINOPHIL COUNT INCREASED 24 0.0029
509 WHITE BLOOD CELL COUNT INCREASED 110 0.0029
510 CHOLESTASIS 55 0.0029
511 DERMATITIS ALLERGIC 36 0.0029
512 SENSORY LOSS 23 0.0029
513 CONDITION AGGRAVATED 868 0.0029
514 CONSTIPATION 620 0.0028
515 BLOOD LACTATE DEHYDROGENASE INCREASED 45 0.0028
516 PNEUMONITIS 77 0.0028
517 CYTOMEGALOVIRUS INFECTION 47 0.0028
518 NECK PAIN 158 0.0028
519 OBESITY 45 0.0028
520 BLOOD GLUCOSE ABNORMAL 52 0.0028
521 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
522 ADRENAL INSUFFICIENCY 34 0.0028
523 ABDOMINAL DISTENSION 292 0.0028
524 DELUSION 43 0.0028
525 MUSCLE SPASTICITY 34 0.0028
526 SQUAMOUS CELL CARCINOMA 26 0.0028
527 PANCYTOPENIA 154 0.0028
528 HEART RATE INCREASED 272 0.0027
529 DEPRESSED MOOD 145 0.0027
530 SPUTUM DISCOLOURED 26 0.0027
531 MUSCLE SPASMS 503 0.0027
532 VISION BLURRED 375 0.0027
533 PAIN IN EXTREMITY 804 0.0027
534 ROTATOR CUFF SYNDROME 35 0.0027
535 RETCHING 58 0.0027
536 COUGH 762 0.0027
537 DRUG TOXICITY 37 0.0027
538 OSTEOARTHRITIS 115 0.0027
539 PLATELET COUNT DECREASED 289 0.0027
540 HYPOPHAGIA 69 0.0027
541 SKIN LESION 74 0.0027
542 PNEUMONIA 868 0.0027
543 DEPRESSED LEVEL OF CONSCIOUSNESS 106 0.0027
544 TREATMENT NONCOMPLIANCE 146 0.0027
545 NEPHROLITHIASIS 122 0.0027
546 MOUTH ULCERATION 56 0.0027
547 INTERVERTEBRAL DISC PROTRUSION 58 0.0027
548 LIMB INJURY 72 0.0026
549 TENDONITIS 41 0.0026
550 DIARRHOEA 1707 0.0026
551 ANXIETY 750 0.0026
552 ALTERED STATE OF CONSCIOUSNESS 57 0.0026
553 ABASIA 65 0.0026
554 THERAPY NON-RESPONDER 118 0.0026
555 RESPIRATORY ARREST 72 0.0026
556 CEREBROVASCULAR ACCIDENT 442 0.0026
557 SLEEP DISORDER 184 0.0026
558 INTERSTITIAL LUNG DISEASE 126 0.0026
559 PHARYNGEAL OEDEMA 40 0.0026
560 GLAUCOMA 50 0.0026
561 MACULAR DEGENERATION 31 0.0026
562 POLYNEUROPATHY 31 0.0026
563 INTRAOCULAR PRESSURE INCREASED 33 0.0026
564 BLISTER 145 0.0026
565 AGEUSIA 64 0.0026
566 SKIN EXFOLIATION 216 0.0026
567 CARDIAC OPERATION 22 0.0026
568 PERITONITIS 53 0.0026
569 SEXUAL DYSFUNCTION 30 0.0026
570 FLATULENCE 145 0.0026
571 LYMPHOCYTE COUNT DECREASED 45 0.0025
572 HEPATOMEGALY 25 0.0025
573 PHARMACEUTICAL PRODUCT COMPLAINT 66 0.0025
574 INTERNAL HAEMORRHAGE 29 0.0025
575 JOINT RANGE OF MOTION DECREASED 34 0.0025
576 HERNIA 49 0.0025
577 BACK PAIN 585 0.0025
578 DRUG-INDUCED LIVER INJURY 79 0.0025
579 PNEUMONIA BACTERIAL 23 0.0025
580 DEMENTIA 70 0.0025
581 CONTUSION 241 0.0025
582 MALNUTRITION 28 0.0025
583 RETINAL DETACHMENT 23 0.0025
584 DYSSTASIA 73 0.0025
585 SEPSIS 278 0.0025
586 SKIN LACERATION 27 0.0025
587 GAMMA-GLUTAMYLTRANSFERASE INCREASED 55 0.0025
588 RIB FRACTURE 51 0.0025
589 PERIPHERAL COLDNESS 34 0.0025
590 OXYGEN SATURATION DECREASED 139 0.0025
591 PHARYNGEAL SWELLING 24 0.0025
592 PAIN OF SKIN 66 0.0024
593 CYSTITIS 78 0.0024
594 DISTURBANCE IN ATTENTION 132 0.0024
595 LIVER INJURY 60 0.0024
596 MUSCULOSKELETAL DISCOMFORT 42 0.0024
597 TREMOR 405 0.0024
598 FULL BLOOD COUNT DECREASED 49 0.0024
599 TOOTHACHE 44 0.0024
600 ABNORMAL DREAMS 67 0.0024
601 STAPHYLOCOCCAL INFECTION 80 0.0024
602 OSTEONECROSIS OF JAW 60 0.0024
603 EAR PAIN 47 0.0024
604 DEEP VEIN THROMBOSIS 157 0.0024
605 ARTHRITIS 190 0.0024
606 TASTE DISORDER 49 0.0024
607 HYPERHIDROSIS 310 0.0024
608 PNEUMONIA ASPIRATION 60 0.0024
609 RHINORRHOEA 155 0.0024
610 RASH GENERALISED 62 0.0024
611 DYSPHONIA 140 0.0024
612 HALLUCINATION, AUDITORY 38 0.0024
613 BLOOD THYROID STIMULATING HORMONE INCREASED 22 0.0024
614 PULMONARY THROMBOSIS 26 0.0024
615 CATARACT 142 0.0024
616 SINUS DISORDER 47 0.0024
617 OSTEOPENIA 36 0.0024
618 DEAFNESS 62 0.0024
619 BRONCHITIS 175 0.0024
620 ENCEPHALOPATHY 58 0.0024
621 OSTEOPOROSIS 97 0.0024
622 SLUGGISHNESS 24 0.0024
623 CHOLECYSTITIS 28 0.0023
624 DYSKINESIA 95 0.0023
625 PAIN IN JAW 66 0.0023
626 DECREASED APPETITE 541 0.0023
627 POST PROCEDURAL HAEMORRHAGE 27 0.0023
628 MALAISE 1017 0.0023
629 WEIGHT DECREASED 647 0.0023
630 PALLOR 63 0.0023
631 BURNING SENSATION 162 0.0023
632 GAIT DISTURBANCE 442 0.0023
633 BLOOD GLUCOSE INCREASED 435 0.0023
634 SOMNOLENCE 462 0.0023
635 CARPAL TUNNEL SYNDROME 32 0.0023
636 ABDOMINAL DISCOMFORT 383 0.0023
637 HYPERTHYROIDISM 33 0.0023
638 BLOOD IRON DECREASED 27 0.0023
639 VOMITING 1069 0.0023
640 GASTROINTESTINAL PAIN 25 0.0023
641 MUSCULOSKELETAL PAIN 119 0.0023
642 JOINT DISLOCATION 24 0.0023
643 RASH PRURITIC 123 0.0023
644 FATIGUE 1763 0.0023
645 OSTEOMYELITIS 41 0.0023
646 APATHY 33 0.0023
647 INJURY 159 0.0023
648 ABDOMINAL PAIN 526 0.0023
649 VISUAL IMPAIRMENT 280 0.0023
650 MOTOR DYSFUNCTION 23 0.0023
651 BACTERIAL INFECTION 42 0.0022
652 BREAST PAIN 24 0.0022
653 JOINT STIFFNESS 59 0.0022
654 STEVENS-JOHNSON SYNDROME 50 0.0022
655 BRONCHOSPASM 32 0.0022
656 RESTLESSNESS 82 0.0022
657 MALIGNANT MELANOMA 30 0.0022
658 BRAIN FOG 35 0.0022
659 RASH PAPULAR 50 0.0022
660 FEMUR FRACTURE 69 0.0022
661 ANAPHYLACTIC REACTION 123 0.0022
662 ARTHRALGIA 918 0.0022
663 PARAESTHESIA 347 0.0022
664 ABDOMINAL PAIN UPPER 454 0.0022
665 SPEECH DISORDER 115 0.0022
666 ASPIRATION 24 0.0022
667 PRODUCT PRESCRIBING ERROR 52 0.0022
668 DYSPHAGIA 207 0.0022
669 HYPOAESTHESIA 326 0.0022
670 EYE SWELLING 81 0.0022
671 EYE HAEMORRHAGE 29 0.0022
672 HAEMATOCHEZIA 119 0.0022
673 EYELID OEDEMA 25 0.0021
674 HEPATITIS 55 0.0021
675 APHONIA 30 0.0021
676 CARDIAC DISORDER 201 0.0021
677 SPINAL FRACTURE 43 0.0021
678 ORAL PAIN 48 0.0021
679 SCHIZOPHRENIA 26 0.0021
680 SKIN CANCER 46 0.0021
681 ORAL CANDIDIASIS 28 0.0021
682 CHROMATURIA 48 0.0021
683 LUNG INFECTION 33 0.0021
684 SEASONAL ALLERGY 30 0.0021
685 THROMBOCYTOPENIA 237 0.0021
686 ERUCTATION 41 0.0021
687 TOXICITY TO VARIOUS AGENTS 357 0.0021
688 NEUROLEPTIC MALIGNANT SYNDROME 25 0.0021
689 ATAXIA 25 0.0021
690 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 49 0.0021
691 ABDOMINAL PAIN LOWER 53 0.0021
692 GENERAL PHYSICAL HEALTH DETERIORATION 242 0.0021
693 SKIN DISCOLOURATION 96 0.0021
694 INSOMNIA 555 0.0021
695 PYREXIA 721 0.0021
696 POST PROCEDURAL COMPLICATION 40 0.0021
697 COORDINATION ABNORMAL 29 0.0021
698 WOUND 58 0.0021
699 CANDIDA INFECTION 35 0.0021
700 SINUS CONGESTION 28 0.0021
701 SCIATICA 33 0.0021
702 RASH MACULO-PAPULAR 46 0.0021
703 LOCALISED INFECTION 50 0.0021
704 ANKLE FRACTURE 32 0.0021
705 PANCREATITIS 109 0.0021
706 BEDRIDDEN 27 0.0021
707 HIP FRACTURE 66 0.0021
708 ASPARTATE AMINOTRANSFERASE INCREASED 109 0.0020
709 CARDIOVASCULAR DISORDER 52 0.0020
710 HEADACHE 1284 0.0020
711 MUSCLE TIGHTNESS 33 0.0020
712 UPPER RESPIRATORY TRACT INFECTION 94 0.0020
713 HEAD DISCOMFORT 36 0.0020
714 LABORATORY TEST ABNORMAL 60 0.0020
715 DRUG ERUPTION 36 0.0020
716 DRUG DISPENSING ERROR 31 0.0020
717 HAEMORRHAGE 212 0.0020
718 PARALYSIS 29 0.0020
719 NIGHT SWEATS 65 0.0020
720 HAIR COLOUR CHANGES 25 0.0020
721 CHOKING 39 0.0020
722 SWELLING 187 0.0020
723 NEUROTOXICITY 35 0.0020
724 BONE PAIN 117 0.0020
725 SECRETION DISCHARGE 25 0.0020
726 MEMORY IMPAIRMENT 274 0.0020
727 DYSGEUSIA 148 0.0020
728 INTESTINAL OBSTRUCTION 75 0.0020
729 EYE PAIN 112 0.0020
730 BRAIN OEDEMA 25 0.0020
731 HEPATOTOXICITY 44 0.0020
732 ALANINE AMINOTRANSFERASE INCREASED 121 0.0020
733 CLOSTRIDIUM DIFFICILE INFECTION 43 0.0020
734 NO THERAPEUTIC RESPONSE 24 0.0020
735 SPINAL PAIN 23 0.0020
736 FEELING HOT 120 0.0020
737 PRURITUS 751 0.0020
738 MOBILITY DECREASED 140 0.0019
739 COVID-19 PNEUMONIA 23 0.0019
740 TENDON RUPTURE 24 0.0019
741 LEUKOPENIA 97 0.0019
742 GASTROENTERITIS VIRAL 35 0.0019
743 QUALITY OF LIFE DECREASED 26 0.0019
744 MYELODYSPLASTIC SYNDROME 28 0.0019
745 MYOCLONUS 23 0.0019
746 LACRIMATION INCREASED 58 0.0019
747 DISSEMINATED INTRAVASCULAR COAGULATION 27 0.0019
748 CARDIO-RESPIRATORY ARREST 80 0.0019
749 CYANOSIS 30 0.0019
750 MOOD ALTERED 52 0.0019
751 NAUSEA 1505 0.0019
752 INFLAMMATION 98 0.0019
753 IMPAIRED HEALING 62 0.0019
754 ABSCESS 30 0.0019
755 FLUSHING 191 0.0019
756 BLOOD GLUCOSE DECREASED 90 0.0019
757 ABNORMAL WEIGHT GAIN 23 0.0019
758 DEPRESSION 423 0.0019
759 BACTERAEMIA 22 0.0019
760 NEURALGIA 45 0.0018
761 HYPERSOMNIA 53 0.0018
762 HEPATIC FUNCTION ABNORMAL 69 0.0018
763 COLITIS 70 0.0018
764 BACK DISORDER 30 0.0018
765 TYPE 2 DIABETES MELLITUS 62 0.0018
766 FEELING ABNORMAL 441 0.0018
767 WEIGHT INCREASED 412 0.0018
768 RESPIRATORY DISORDER 55 0.0018
769 CONVULSION 105 0.0018
770 PNEUMOTHORAX 29 0.0018
771 SNEEZING 41 0.0018
772 OROPHARYNGEAL PAIN 169 0.0018
773 ULCER 29 0.0018
774 DEVICE RELATED INFECTION 28 0.0018
775 LIVER FUNCTION TEST INCREASED 39 0.0018
776 THYROID DISORDER 28 0.0018
777 GENERALISED TONIC-CLONIC SEIZURE 30 0.0018
778 BLOOD TRIGLYCERIDES INCREASED 32 0.0018
779 SENSORY DISTURBANCE 29 0.0018
780 UPPER LIMB FRACTURE 36 0.0018
781 AGITATION 132 0.0018
782 ORAL HERPES 35 0.0018
783 NEUTROPHIL COUNT DECREASED 73 0.0018
784 DRUG RESISTANCE 46 0.0018
785 HERPES ZOSTER 102 0.0018
786 VIRAL INFECTION 59 0.0018
787 BLINDNESS UNILATERAL 25 0.0018
788 THINKING ABNORMAL 33 0.0018
789 RASH ERYTHEMATOUS 83 0.0017
790 EPILEPSY 53 0.0017
791 PARAESTHESIA ORAL 25 0.0017
792 SEDATION 45 0.0017
793 NEUROPATHY PERIPHERAL 163 0.0017
794 LIMB DISCOMFORT 53 0.0017
795 FREQUENT BOWEL MOVEMENTS 46 0.0017
796 CYTOKINE RELEASE SYNDROME 34 0.0017
797 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48 0.0017
798 DRUG ABUSE 141 0.0017
799 EXTRAPYRAMIDAL DISORDER 42 0.0017
800 GALLBLADDER DISORDER 30 0.0017
801 SEPTIC SHOCK 73 0.0017
802 ROAD TRAFFIC ACCIDENT 70 0.0017
803 SEIZURE 193 0.0017
804 RESPIRATORY DISTRESS 46 0.0017
805 ACTIVITIES OF DAILY LIVING IMPAIRED 33 0.0017
806 DRUG PRESCRIBING ERROR 32 0.0017
807 TRANSAMINASES INCREASED 37 0.0017
808 THROAT TIGHTNESS 45 0.0017
809 RASH 725 0.0017
810 DRY EYE 83 0.0017
811 ARTHROPATHY 92 0.0017
812 EATING DISORDER 35 0.0016
813 SCAR 28 0.0016
814 PSYCHOTIC DISORDER 48 0.0016
815 COVID-19 285 0.0016
816 LIVER DISORDER 72 0.0016
817 GAIT INABILITY 54 0.0016
818 RESPIRATORY TRACT INFECTION 42 0.0016
819 PRESCRIBED UNDERDOSE 32 0.0016
820 METASTASES TO LIVER 28 0.0016
821 BLOOD BILIRUBIN INCREASED 43 0.0016
822 ERYTHEMA 327 0.0016
823 GASTROINTESTINAL DISORDER 142 0.0016
824 EYE DISORDER 52 0.0016
825 POOR QUALITY SLEEP 34 0.0016
826 RESPIRATORY TRACT CONGESTION 25 0.0016
827 RASH MACULAR 55 0.0016
828 PAIN 963 0.0016
829 MENTAL IMPAIRMENT 38 0.0016
830 BLOOD CHOLESTEROL INCREASED 73 0.0016
831 INTENTIONAL PRODUCT MISUSE 137 0.0016
832 CHILLS 183 0.0016
833 WRONG TECHNIQUE IN DRUG USAGE PROCESS 56 0.0015
834 WHITE BLOOD CELL COUNT DECREASED 167 0.0015
835 SUICIDE ATTEMPT 93 0.0015
836 COMA 73 0.0015
837 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 109 0.0015
838 NASAL CONGESTION 90 0.0015
839 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
840 MOVEMENT DISORDER 49 0.0015
841 HYPOAESTHESIA ORAL 23 0.0015
842 METASTASES TO BONE 25 0.0015
843 DRUG EFFECT DECREASED 82 0.0015
844 ANAPHYLACTIC SHOCK 39 0.0015
845 COMPLETED SUICIDE 126 0.0015
846 INFLUENZA 167 0.0015
847 UNEVALUABLE EVENT 113 0.0015
848 TARDIVE DYSKINESIA 42 0.0015
849 PHOTOPHOBIA 28 0.0015
850 DISEASE PROGRESSION 176 0.0015
851 HYPOACUSIS 64 0.0015
852 HOT FLUSH 112 0.0015
853 INTENTIONAL SELF-INJURY 30 0.0015
854 INTENTIONAL OVERDOSE 95 0.0015
855 FOOT FRACTURE 28 0.0015
856 BONE MARROW FAILURE 30 0.0015
857 SINUSITIS 151 0.0015
858 HOSPITALISATION 226 0.0015
859 PROSTATE CANCER 118 0.0015
860 THERAPY CESSATION 75 0.0015
861 JOINT INJURY 31 0.0014
862 SURGERY 85 0.0014
863 DRUG INTOLERANCE 140 0.0014
864 HEPATIC ENZYME INCREASED 98 0.0014
865 INFECTION 208 0.0014
866 HEPATIC CIRRHOSIS 27 0.0014
867 DERMATITIS 30 0.0014
868 HYPERSENSITIVITY 265 0.0014
869 MUSCULOSKELETAL STIFFNESS 125 0.0014
870 DISCOMFORT 87 0.0014
871 FEELING JITTERY 27 0.0014
872 NASOPHARYNGITIS 260 0.0014
873 STOMATITIS 85 0.0014
874 PANIC ATTACK 51 0.0014
875 GASTRIC DISORDER 48 0.0014
876 OVERDOSE 300 0.0014
877 DRUG EFFECT INCOMPLETE 50 0.0014
878 BONE DISORDER 25 0.0014
879 INFLUENZA LIKE ILLNESS 112 0.0014
880 FEBRILE NEUTROPENIA 90 0.0014
881 LOWER LIMB FRACTURE 26 0.0014
882 AGRANULOCYTOSIS 25 0.0013
883 PRODUCT ADMINISTRATION ERROR 27 0.0013
884 EMOTIONAL DISTRESS 160 0.0013
885 INTENTIONAL PRODUCT USE ISSUE 115 0.0013
886 IRRITABLE BOWEL SYNDROME 28 0.0013
887 LYMPHADENOPATHY 46 0.0013
888 INTENTIONAL DOSE OMISSION 37 0.0013
889 PRESCRIBED OVERDOSE 25 0.0013
890 PLASMA CELL MYELOMA 50 0.0013
891 SKIN FISSURES 25 0.0013
892 URTICARIA 213 0.0013
893 EYE IRRITATION 73 0.0013
894 PRODUCT SUBSTITUTION ISSUE 73 0.0013
895 FRACTURE 24 0.0013
896 NEUTROPENIA 170 0.0012
897 CONJUNCTIVITIS 23 0.0012
898 DRUG INEFFECTIVE 1631 0.0012
899 INFUSION RELATED REACTION 82 0.0012
900 THROAT IRRITATION 55 0.0012
901 NERVOUSNESS 64 0.0012
902 MOOD SWINGS 39 0.0012
903 DISABILITY 24 0.0012
904 ANGER 41 0.0012
905 PANCREATIC CARCINOMA 35 0.0012
906 DRUG ADMINISTRATION ERROR 37 0.0012
907 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
908 GYNAECOMASTIA 37 0.0012
909 PRODUCT DOSE OMISSION 78 0.0012
910 HEPATIC FAILURE 36 0.0012
911 NERVOUS SYSTEM DISORDER 37 0.0012
912 MIGRAINE 113 0.0012
913 DISEASE RECURRENCE 56 0.0012
914 DRY SKIN 157 0.0012
915 MALIGNANT NEOPLASM PROGRESSION 120 0.0012
916 ECZEMA 61 0.0012
917 OCULAR HYPERAEMIA 55 0.0012
918 OFF LABEL USE 1012 0.0012
919 MUCOSAL INFLAMMATION 30 0.0011
920 KNEE ARTHROPLASTY 24 0.0011
921 SKIN DISORDER 38 0.0011
922 THERAPEUTIC RESPONSE DECREASED 69 0.0011
923 ACCIDENTAL OVERDOSE 41 0.0011
924 AGGRESSION 56 0.0011
925 GLOSSODYNIA 25 0.0011
926 INCORRECT DRUG ADMINISTRATION DURATION 31 0.0011
927 THERAPEUTIC RESPONSE UNEXPECTED 49 0.0011
928 DEATH 940 0.0011
929 EAR INFECTION 29 0.0011
930 SUICIDAL IDEATION 99 0.0011
931 OSTEONECROSIS 35 0.0011
932 PRODUCT USE IN UNAPPROVED INDICATION 261 0.0011
933 FUNGAL INFECTION 35 0.0010
934 ALOPECIA 205 0.0010
935 ABNORMAL BEHAVIOUR 41 0.0010
936 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
937 BONE DENSITY DECREASED 32 0.0010
938 ILL-DEFINED DISORDER 62 0.0010
939 IRRITABILITY 61 0.0010
940 THERAPY INTERRUPTED 72 0.0010
941 RHEUMATOID ARTHRITIS 114 0.0010
942 FIBROMYALGIA 24 0.0010
943 INCORRECT DOSE ADMINISTERED 224 0.0010
944 ADVERSE DRUG REACTION 88 0.0010
945 PRODUCT USE ISSUE 184 0.0010
946 PRODUCT QUALITY ISSUE 132 0.0010
947 MENTAL DISORDER 42 0.0010
948 INJECTION SITE HAEMORRHAGE 74 0.0009
949 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50 0.0009
950 EMOTIONAL DISORDER 28 0.0009
951 EXPIRED PRODUCT ADMINISTERED 30 0.0009
952 NEOPLASM MALIGNANT 59 0.0009
953 DRUG DOSE OMISSION 145 0.0009
954 SYSTEMIC LUPUS ERYTHEMATOSUS 31 0.0009
955 PSORIASIS 114 0.0009
956 ADVERSE EVENT 77 0.0008
957 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 147 0.0008
958 ILLNESS 84 0.0008
959 NEOPLASM PROGRESSION 28 0.0008
960 PSORIATIC ARTHROPATHY 32 0.0008
961 UNDERDOSE 55 0.0008
962 INJECTION SITE BRUISING 59 0.0007
963 WITHDRAWAL SYNDROME 31 0.0007
964 COLITIS ULCERATIVE 32 0.0007
965 CRYING 26 0.0007
966 MULTIPLE SCLEROSIS RELAPSE 48 0.0007
967 MYELOSUPPRESSION 25 0.0007
968 PRODUCT DOSE OMISSION ISSUE 202 0.0007
969 LUNG NEOPLASM MALIGNANT 28 0.0007
970 MULTIPLE SCLEROSIS 32 0.0007
971 EXTRA DOSE ADMINISTERED 27 0.0007
972 INJECTION SITE PAIN 195 0.0006
973 SKIN IRRITATION 28 0.0006
974 DERMATITIS ATOPIC 31 0.0006
975 THERAPEUTIC PRODUCT EFFECT DECREASED 26 0.0006
976 DRUG WITHDRAWAL SYNDROME 50 0.0006
977 BLADDER CANCER 33 0.0006
978 ACNE 42 0.0006
979 SKIN BURNING SENSATION 39 0.0005
980 DEVICE ISSUE 48 0.0005
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 108 0.0005
982 MATERNAL EXPOSURE DURING PREGNANCY 47 0.0005
983 NO ADVERSE EVENT 92 0.0005
984 TREATMENT FAILURE 39 0.0005
985 INJECTION SITE SWELLING 35 0.0005
986 DEVICE MALFUNCTION 31 0.0004
987 INJECTION SITE ERYTHEMA 52 0.0004
988 EXPOSURE DURING PREGNANCY 24 0.0004
989 INJECTION SITE REACTION 24 0.0003
990 INJECTION SITE PRURITUS 23 0.0003
991 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
992 BREAST CANCER 30 0.0003
993 ACCIDENTAL EXPOSURE TO PRODUCT 30 0.0003
994 DRUG DEPENDENCE 26 0.0002